BR0309357A - Método para fabricar cristais de esteróides, cristais obtìveis de acordo com esse método, e formulações farmacêuticas - Google Patents
Método para fabricar cristais de esteróides, cristais obtìveis de acordo com esse método, e formulações farmacêuticasInfo
- Publication number
- BR0309357A BR0309357A BR0309357-3A BR0309357A BR0309357A BR 0309357 A BR0309357 A BR 0309357A BR 0309357 A BR0309357 A BR 0309357A BR 0309357 A BR0309357 A BR 0309357A
- Authority
- BR
- Brazil
- Prior art keywords
- crystals
- pharmaceutical formulations
- obtainable
- steroid
- particle size
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 150000003431 steroids Chemical class 0.000 title abstract 3
- 239000002245 particle Substances 0.000 abstract 2
- 238000001238 wet grinding Methods 0.000 abstract 2
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
"MéTODO PARA FABRICAR CRISTAIS DE ESTERóIDES, CRISTAIS OBTìVEIS DE ACORDO COM ESSE MéTODO, E FORMULAçõES FARMACêUTICAS". Sendo o tamanho médio de partícula situa-se em uma faixa pré-determinada e cujo tamanho máximo de partícula não ultrapassa um valor pré-determinado, sendo que uma solução supersaturada dos esteróides, é submetida a uma moagem úmida durante a cristalização por meio de um dispositivo para moagem úmida, sendo obtida uma suspensão de grão primário. Além disso, são descritos cristais obtíveis com base nesse método bem como formulações farmacêuticas, que contém esses cristais.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10218107A DE10218107A1 (de) | 2002-04-23 | 2002-04-23 | Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
| PCT/EP2003/004154 WO2003091272A1 (de) | 2002-04-23 | 2003-04-22 | Verfahren zum herstellen von kristallen von steroiden, danach erhältliche kristalle und deren verwendung in pharmazeutischen formulierungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0309357A true BR0309357A (pt) | 2005-02-22 |
Family
ID=29264787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0309357-3A BR0309357A (pt) | 2002-04-23 | 2003-04-22 | Método para fabricar cristais de esteróides, cristais obtìveis de acordo com esse método, e formulações farmacêuticas |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7148212B2 (pt) |
| EP (1) | EP1497308B1 (pt) |
| JP (1) | JP4490116B2 (pt) |
| KR (1) | KR20040106380A (pt) |
| CN (1) | CN1646555A (pt) |
| AT (1) | ATE340186T1 (pt) |
| AU (1) | AU2003232491A1 (pt) |
| BR (1) | BR0309357A (pt) |
| CA (1) | CA2480004C (pt) |
| DE (2) | DE10218107A1 (pt) |
| DK (1) | DK1497308T3 (pt) |
| ES (1) | ES2274258T3 (pt) |
| IL (1) | IL163986A0 (pt) |
| MX (1) | MXPA04010467A (pt) |
| NO (1) | NO20045023L (pt) |
| PL (1) | PL371340A1 (pt) |
| PT (1) | PT1497308E (pt) |
| RU (1) | RU2315056C2 (pt) |
| WO (1) | WO2003091272A1 (pt) |
| ZA (1) | ZA200409401B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10218109A1 (de) * | 2002-04-23 | 2003-11-20 | Jenapharm Gmbh | Verfahren zum Herstellen von Kristallen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
| US20080038350A1 (en) * | 2006-08-10 | 2008-02-14 | Hagen Gerecke | Low-dosage peroral medication for contraception containing crystalline dienogest and ethinyl estradiol |
| DE502006003892D1 (de) * | 2006-08-10 | 2009-07-16 | Bayer Schering Pharma Ag | Perorale Arzneiform mit Dienogest und Ethinylestradiol zur Kontrazeption |
| DE102008037025C5 (de) | 2008-08-08 | 2016-07-07 | Jesalis Pharma Gmbh | Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform |
| DE102010003711B4 (de) * | 2010-04-08 | 2015-04-09 | Jesalis Pharma Gmbh | Verfahren zur Herstellung kristalliner Wirkstoffpartikel |
| RU2642244C2 (ru) * | 2010-04-12 | 2018-01-24 | Кларус Терапеутикс, Инк. | Оральные фармацевтические композиции сложных эфиров тестостерона и способы лечения недостатка тестостерона с их использованием |
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| WO2015173157A2 (en) | 2014-05-13 | 2015-11-19 | Akzo Nobel Chemicals International B.V. | Process to crystallize chelating agents |
| US20160361322A1 (en) | 2015-06-15 | 2016-12-15 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
| US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
| AU2019308326B2 (en) | 2018-07-20 | 2025-07-31 | Lipocine Inc. | Liver disease |
| WO2021230308A1 (ja) | 2020-05-15 | 2021-11-18 | 塩野義製薬株式会社 | 不純物の生成を抑制した医薬組成物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3226389A (en) | 1962-01-04 | 1965-12-28 | Du Pont | 11,11,12,12-tetracyano-naphtho-2,6-quinodimethan and its anion-radical salts |
| HU209603B (en) | 1988-10-05 | 1994-09-28 | Upjohn Co | Process for production of solid powders in finalydivided microcristallin form |
| DE3917617A1 (de) * | 1989-05-31 | 1990-12-06 | Boehringer Ingelheim Kg | Mikronisierte bioabbaubare partikel, verfahren zur ihrer herstellung und ihre verwendung |
| FR2668945B1 (fr) | 1990-11-12 | 1993-02-19 | Theramex | Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus. |
| ES2126977T3 (es) | 1991-07-10 | 1999-04-01 | Chiyoda Chem Eng Construct Co | Procedimento para la produccion de aducto cristalino de bisfenol a y fenol. |
| NZ248813A (en) * | 1992-11-25 | 1995-06-27 | Eastman Kodak Co | Polymeric grinding media used in grinding pharmaceutical substances |
| DE4332283A1 (de) * | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| AU677141B2 (en) * | 1993-12-27 | 1997-04-10 | Nippon Soda Co., Ltd. | 4-hydroxy-4'-isopropoxydiphenyl sulfone developer composition, wet pulverizing method, and dispersion |
| US5718388A (en) * | 1994-05-25 | 1998-02-17 | Eastman Kodak | Continuous method of grinding pharmaceutical substances |
| US5534270A (en) * | 1995-02-09 | 1996-07-09 | Nanosystems Llc | Method of preparing stable drug nanoparticles |
| CN1183102C (zh) * | 1998-12-25 | 2005-01-05 | 第一精密化学株式会社 | 泛酸钙的制备方法 |
| EP1157996A1 (de) * | 2000-05-23 | 2001-11-28 | JENAPHARM GmbH | Neue Festkörperformen des Mesoprogestins 11Beta-[4E-(Hydroxyiminomethyl)-phenyl]-17Alpha-methoxymethyl-17Beta-methoxy-estra-4,9-dien-3-on |
| DE10218109A1 (de) * | 2002-04-23 | 2003-11-20 | Jenapharm Gmbh | Verfahren zum Herstellen von Kristallen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen |
-
2002
- 2002-04-23 DE DE10218107A patent/DE10218107A1/de not_active Ceased
-
2003
- 2003-04-17 US US10/417,557 patent/US7148212B2/en not_active Expired - Lifetime
- 2003-04-22 BR BR0309357-3A patent/BR0309357A/pt not_active IP Right Cessation
- 2003-04-22 ES ES03747107T patent/ES2274258T3/es not_active Expired - Lifetime
- 2003-04-22 RU RU2004134324/04A patent/RU2315056C2/ru not_active IP Right Cessation
- 2003-04-22 CA CA002480004A patent/CA2480004C/en not_active Expired - Lifetime
- 2003-04-22 DE DE50305122T patent/DE50305122D1/de not_active Expired - Lifetime
- 2003-04-22 MX MXPA04010467A patent/MXPA04010467A/es unknown
- 2003-04-22 CN CNA038090376A patent/CN1646555A/zh active Pending
- 2003-04-22 DK DK03747107T patent/DK1497308T3/da active
- 2003-04-22 JP JP2003587830A patent/JP4490116B2/ja not_active Expired - Fee Related
- 2003-04-22 PL PL03371340A patent/PL371340A1/xx not_active Application Discontinuation
- 2003-04-22 KR KR10-2004-7017079A patent/KR20040106380A/ko not_active Withdrawn
- 2003-04-22 AT AT03747107T patent/ATE340186T1/de not_active IP Right Cessation
- 2003-04-22 WO PCT/EP2003/004154 patent/WO2003091272A1/de not_active Ceased
- 2003-04-22 PT PT03747107T patent/PT1497308E/pt unknown
- 2003-04-22 IL IL16398603A patent/IL163986A0/xx unknown
- 2003-04-22 EP EP03747107A patent/EP1497308B1/de not_active Expired - Lifetime
- 2003-04-22 AU AU2003232491A patent/AU2003232491A1/en not_active Abandoned
-
2004
- 2004-11-18 NO NO20045023A patent/NO20045023L/no not_active Application Discontinuation
- 2004-11-22 ZA ZA200409401A patent/ZA200409401B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1497308A1 (de) | 2005-01-19 |
| US7148212B2 (en) | 2006-12-12 |
| ZA200409401B (en) | 2006-02-22 |
| CN1646555A (zh) | 2005-07-27 |
| DE50305122D1 (de) | 2006-11-02 |
| MXPA04010467A (es) | 2004-12-13 |
| KR20040106380A (ko) | 2004-12-17 |
| CA2480004A1 (en) | 2003-11-06 |
| DE10218107A1 (de) | 2003-11-20 |
| JP4490116B2 (ja) | 2010-06-23 |
| US20030216360A1 (en) | 2003-11-20 |
| DK1497308T3 (da) | 2007-01-29 |
| RU2315056C2 (ru) | 2008-01-20 |
| NO20045023L (no) | 2004-11-18 |
| CA2480004C (en) | 2007-11-13 |
| JP2005524698A (ja) | 2005-08-18 |
| RU2004134324A (ru) | 2006-02-10 |
| ATE340186T1 (de) | 2006-10-15 |
| PT1497308E (pt) | 2007-01-31 |
| EP1497308B1 (de) | 2006-09-20 |
| IL163986A0 (en) | 2005-12-18 |
| AU2003232491A1 (en) | 2003-11-10 |
| PL371340A1 (en) | 2005-06-13 |
| WO2003091272A1 (de) | 2003-11-06 |
| ES2274258T3 (es) | 2007-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0309357A (pt) | Método para fabricar cristais de esteróides, cristais obtìveis de acordo com esse método, e formulações farmacêuticas | |
| DE60332776D1 (de) | Herstellung von Delta-9-Tetrahydrocannabinol | |
| CA2225250A1 (en) | Bicyclic amino derivatives and pgd2 antagonist containing the same | |
| SE9903760D0 (sv) | New compounds | |
| BRPI0408369A (pt) | derivados de indol úteis para o tratamento de doenças | |
| BRPI0409227A (pt) | composto, composição farmacêutica, uso de um composto, intermediário, e, processo para a preparação de um composto | |
| BR0311494A (pt) | Novos indóis substituìdos | |
| BR0112756A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto | |
| BRPI0415657A (pt) | derivados de alcanamina de diidrobenzofuranila como agonistas de 5ht2c | |
| SG151254A1 (en) | Substituted morpholine and thiomorpholine derivatives | |
| BR0007778A (pt) | Peptidila cetonas heterocìclicas úteis como inibidores de triptase | |
| BR9910908A (pt) | Indenopirrolocarbazóis ligados em ponte | |
| NO20055562L (no) | Substituerte indolin- og indolderivater | |
| BR0304937B1 (pt) | composição de antiespumante de silicone encapsulado e processo para a produção de uma composição de antiespumante de silicone encapsulado. | |
| PE20030122A1 (es) | Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram | |
| PE20030588A1 (es) | Metodos para granulacion humeda de azitromicina | |
| MX2007011695A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| AR011409A1 (es) | Derivados de 16-hidroxi-11-(fenil substituido)-estra-4,9-dieno, su utilizacion, un procedimiento para prepararlos, formulaciones farmaceuticasque comprenden a dichos derivados, y un compuesto utilizable como intermediario para prepararlos | |
| TR200400526T4 (tr) | Göz kurumasının tedavisi için lipoksin A4 ve analogları | |
| SE8301008L (sv) | Pyrrolacetamider med antiinflammatorisk verkan | |
| AR038658A1 (es) | Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento | |
| BR0309358A (pt) | Processo para fabricar cristais de substâncias ativas medicinais, cristais obtìveis com base nesse método e formulações farmacêuticas | |
| AR029461A1 (es) | Derivados de 4-fenil-1-piperazinilo, - piperidinilo y -tetrahidropiridilo , composiciones farmaceuticas que los comprenden y el uso de los mismos para la fabricacion de un medicamento | |
| MX2007011698A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| ATE374195T1 (de) | Indazol-3-one und analoga und derivate davon, die die funktion des vanilloid-1-rezeptors (vr1) modulieren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010. |